Lisata Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

Lisata Therapeutics

29/02/2024 22:49

* Lisata Therapeutics Inc  LSTA.OQ  reported a quarterly
adjusted
loss of 66 cents​​ per share for the quarter ended in December,
higher than the same quarter last year, when the company
reported EPS of -76 cents.  The mean expectation of two analysts
for the quarter was for a loss of 89 cents per share. 
    * Reported revenue was zero​; analysts expected zero. 
    * Lisata Therapeutics Inc's reported EPS for the quarter was
a
loss of 66 cents​.
    * The company reported a quarterly loss of $5.37 million.
    * Lisata Therapeutics Inc shares had risen by 15.7% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for Lisata
Therapeutics Inc is $15.50 
This summary was machine generated from LSEG data February 29 at
10:49 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.89          -0.66          Beat
 Sep. 30 2023      -0.93          -0.65          Beat
 Jun. 30 2023      -0.70          -0.50          Beat
 Mar. 31 2023      -0.81          -0.77          Beat